Maverick Protocol vs Mira — how do they compare? Maverick Protocol trades at Rp163.01 (market cap Rp189,88M, Rp38,26M 24h volume), while Mira trades at Rp700.06 (market cap Rp224,01M, Rp102,95M 24h volume). The key difference: Mira is the larger of the two by market cap, and Maverick Protocol's circulating supply is 1,2B / 2B MAV (59%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Maverick Protocol for 25 Days and Mira for 22 Days on average.
| MAV | MIRA | |
|---|---|---|
Market Cap | Rp189,88M | Rp224,01M |
Volume (24h) | Rp38,26M | Rp102,95M |
Circulating Supply | 1,2B / 2B MAV (59%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 25 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
Maverick Protocol (MAV) is trading at Rp158.89 with a market cap of Rp185.72M, showing a bullish overall technical signal. The current price is near the pivot point of Rp159, with oscillators indicating strength but moving averages suggesting caution. Token circulation is at 59%, with a relatively short average hold time of 25 days, reflecting active trading. Recent news appears unrelated to the crypto project, indicating a need for verified protocol updates.
The outlook is cautiously optimistic due to bullish oscillators and proximity to resistance, but risks include low liquidity, potential misidentified news, and bearish moving averages. Key opportunities lie in breaking above Rp165 resistance, while major risks involve volatility from thin trading volumes and lack of recent fundamental developments for the token.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
Maverick Protocol is a DeFi infrastructure provider focused on enhancing industry efficiency, powered by Maverick AMM. Maverick is backed by Founders Fund, Pantera Capital, Coinbase Ventures, Binance Labs, Circle Ventures, Gemini, etc. Maverick is eliminating inefficiency from DeFi by helping users put their liquidity where it can do the most work, hence providing smoother and more efficient transactions. This addresses some of the liquidity challenges that have historically troubled the DeFi space.
Read more on MAV →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →